SCHEMBL17206707

SCHEMBL17206707

CCOC(=O)N[C@H]1CC[C@H](N/C(=N\C(=O)c2ccc(F)c(F)c2)NC2CCC(C)CC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.43
TAS1R1 Q7RTX1 2/20 0.43
TAS1R2 Q8TE23 2/20 0.43
CHRM1 P11229 2/20 0.43
MCHR1 Q99705 6/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CYP2C9 P11712 2/20 0.38
MAPK14 Q16539 2/20 0.38
NPC1 O15118 1/20 0.38
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
AR P10275 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924156 0.96 CHRM1 (0.45) TAS1R3TAS1R1TAS1R2CHRM1MCHR1
SCHEMBL17206716 0.93 CHRM1 (0.43) TAS1R3TAS1R1TAS1R2CHRM1MCHR1
SCHEMBL9924432 0.93 CHRM1 (0.43) TAS1R3TAS1R1TAS1R2CHRM1MCHR1
SCHEMBL17206712 0.92 CHRM1 (0.43) TAS1R3TAS1R1TAS1R2CHRM1MCHR1
SCHEMBL17206703 0.89 CHRM1 (0.41) TAS1R3TAS1R1TAS1R2CHRM1MCHR1
SCHEMBL9924076 0.88 CHRM1 (0.41) TAS1R3TAS1R1TAS1R2CHRM1MCHR1
SCHEMBL9923856 0.86 CHRM1 (0.42) CHRM1MCHR1POLBALDH1A1CYP2C9
SCHEMBL9924158 0.86 CHRM1 (0.42) TAS1R3TAS1R1TAS1R2CHRM1MCHR1
SCHEMBL9924154 0.85 CHRM1 (0.40) TAS1R3TAS1R1TAS1R2CHRM1MCHR1
SCHEMBL9924247 0.85 TAS1R3 (0.48) TAS1R3TAS1R1TAS1R2MCHR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed